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I. Introduction
Before the introduction of streptomycin, bone and joint tuberculosis was one
of the most dangerous diseases for human being. M. C. Wilkinson26 ) has stated
that there were three important causes of death from bone and joint tuberculosis
in pre-antibiotic days: that is, miliary tuberculosis, secondary septic infection
and other complicated tuberculous lesions. ]. Dobson5l has mentioned that
judging from his observation of 320 cases of hip joint tuberculosis, prognosis of
patients with bone and joint tuberculosis becomes very serious when any tuber-
culous lesions develop into other organs. He has stated that miliary tuberculosis
is the most common cause of death from bone and joint tuberculosis.
Since S. A. Waksman22 ) has discovered streptomycin, causal treatments for
tuberculosis have become possible. In the field of the treatment for bone and
joint tuberculosis, the mortality was much decreased and various epochal treat-
ments have been devised. In the former reportI5 ) of the present author, the
literature on the streptomycin treatment for bone and joint tuberculosis has
been reviewed.
E. KondoI3) has reported that the mortality of this disease has much decreased
and the surgical treatment has become much safer with the use of streptomycin.
R. Roaf2°) has also published that the surgical operation upon the tuberculous
foci of bone and joint has become safer but he has suggested the occurrence of
resistant strains in the caseous foci into which the penetration of the strepto-
mycin was not enough to inhibit the bacilli. A. R. AlIenI) has described that the
* This paper was read at the 31st Annual Meeting of the Japanese Orthopaedic Association at
Tokyo, on April 9th, 1958.




tuberculous foci can not be sterilized with streptomycin alone. F. Jansey12) has
expressed a similar opinion that streptomycin should not be used as a substitute
for surgical cleansing. M. C. Wilkinson27) has mentioned that streptomycin can
not penetrate into the chronic tuberculous foci which are enclosed by fibrous
tissue wall because of its avascularity, and that some surgical procedures to
open a pathway are necessary for the drug to enter the foci. H. Stevenson23)
has insisted that in orthopaedic tuberculosis, diseased bone should be removed
before the chemotherapy, if it exists. D. M. Bosworth3) has the same opinion
as H. Stevenson that surgical procedures are necessary in the treatment of bone
tuberculosis, because streptomycin upon the closed foci is not so effective when
it is used without surgery. The Public Health Service Co-operative Investigation19)
of the United States has expressed the same opinion as R. Roaf21 ) and M. C.
Wilkinson27) that the drug can not penetrate into such foci based on the results
of radiographic examination.
R. Harrisll \ B. Mukopodadhayal7) and E. T. Evans6 ) have reported that the
best results were obtained when surgical treatment and streptomycin were com-
bined. R. K. Ghomley8) has published that streptomycin is more effective when
it is used with surgery than when it is used without surgery. M. S. DeRoy4)
has a similar opinion as Ghomley that the development of the closed bone foci
can not be arrested by streptomycin alone and the surgical drainage is necessary
with the drug.
These preceeding reports may be summarized as follows:
1) The mortality of bone and joint tuberculosis has been much decreased
since the introduction of streptomycin.
2) The tuberculous foci themselves can not be cured by conservative treat-
ment with the administration of the drug alone.
3) The most excellent results in the treatment for bone and joint tuber-
culosis have been obtained by the direct surgical procedure on the foci combined
with the drug.
4) The direct operation has become "much safer with the use of the strepto-
mycin treatment.
The rapid decrease of mortality since the introduction of streptomycin may
be explained by the prevention of the metastasis of the bacilli. It is clear that
the danger of the bacilli dissemination increases when the focus is treated
surgically, compared with the conservative treatment. Besides E. Kondo13) and R.
RoaPO), J. A. Weinberg25 ) and S. Orelp8) have reported that the surgical treatment
becomes safer when the streptomycin is administered and the present author
believes that these reports on surgical operation were originated from the
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prevention of the bacilli dissemination by the drug. He14 ) has assayed the strepto-
mycin concentration in the circulating blood of seventeen cases of bone and joint
tuberculosis at various intervals successively after the intramuscular administra-
tion of the drug. He has found that the effective concentrations of the strepto-
mycin are maintained in the cirCUlating blood during twelve hours after the
administration of 250 or 500 milligrams of the drug.
The author15 ) has also assayed the distribution of streptomycin in various
pathological tissues of the foci: cold pus, granulation, caseous mass, sequestrum,
scar, etc., which were removed from the foci of sixty-one cases of bone and joint
tuberculosis at various intervals after the intramuscular administration. The
results showed that in most cases streptomycin did not penetrate into such
pathological tissues, above all dead ones.
Judging from these results streptomycin administered intramuscularly can
inhibit the bacilli which have emigrated into the circulating blood to prevent the
metastasis or dissemination both in conservative and surgical treatment. However,
the foci themselves are not curable with streptomycin alone as mentioned above,
because the sufficient concentration of the drug can not penetrate into the foci.
Accordingly, the pathological tissues of the foci should be removed with surgery.
In these clinical experiments14 ,15), the author had reservations about the
results of low streptomycin concentration in the dead tissues of the foci by the
following reasons. How does the dead tissue prevent the streptomycin from
penetrating into the foci? Whether the dead tissues of the foci such as caseous
mass destroy the chemical construction of the drug or adsorb the drug itself or
the penetration of the drug is very poor2,8,9)? In the former two cases, the
exact assay of streptomycin concentration in the foci may not be done. Although
the results of the clinical experiments15 ) showed that the concentration in dead
tissue was very low, a higher concentration of the drug might have penetrated
into the foci. Following experiment was done to decide whether the caseous
mass had any influences (chemical or physical) upon the streptomycin to decrease
its titer or not.
II. Experiment
1. Material and Method
In this experiment caseous mass was used as a typical representative of the
dead tissues, because it can be obtained from a cold abcess in a large quantity
and in the same nature.
Cold pus was aspirated from the lesions of bone and joint tuberculosis of
eleven cases in which no antibiotics had been administered for one week before
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the aspiration, therefore, these materials were considered not to contain any
antibiotics. One portion of each sample was homogenized, and the other was
separated by centrifugation into the supernatant layer of pus serum and the
sediment of caseous mass.
The method of the experiment were: A certain dosage of streptomycin was
added to both cold pus and pus serum in a definite proportion. And then the
concentration of the drug was assayed at definite times after the addition in
order to examine the changes of the titer of the drug to answer the question of
whether the caseous mass had any influence upon the streptomycin titer. The
details are follows:
1) Four series of sterile test tubes were prepared for each aspirated sample,
each series consisting of twelve tubes.
Series A: Homogenized cold pus was poured in the amount of 4.5 m!. into each
tube. Therefore each of the tubes contained pus serum and caseous mass, all
the elements of tuberculous cold pus.
Series B: The pus serum separated from the same sample as Series A was
poured in 4.5 m!. into each tube.
Series C: MilS sterile phosphate buffer solution at pH 7.8 was poured in 4.5 m!.
into each tube.
Series D: Eleven tubes of this Series were made with serially diluted solutions
of streptomycin ranging from 1,0001' per m!. in the first tube through 500, 250,
125, 63, 32, 16, and so on to 11' per m!. in the eleventh tube dissolved in MilS
sterile phosphate buffer solution at pH 7.8. The twelfth tube contained the
buffer solution alone.
2) 0.5 m!. of streptomycin solution from each tube of Series D was added
to each tube of Series A, Band C, respectively, and then mixed by shaking.
When the contents were mixed up and became homogenous, streptomycin con-
centration in the first tubes of Series A, Band C should be 100r1m!. according
to the following formula.
~12-000,x0.5 = 100'/m!.
4.5 ml +0.5 ml.
In this way, the concentration in the second tubes should be 501' per ml.,
and in the eleventh tubes of the three series, it sould be 0.11' per m!. The first
tubes of each Series were marked as AI' B I , and C I ; the second tubes, as A z ,
Bz , and Cz , respectively, and in this way, the eleventh tubes were marked as
All' B ll and C ll • The twelfth tubes were used as controls to which streptomycin
was not added.
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3) As widely known, a cavity of a tuberculous abcess with cold pus has
very poor metabolism. Therefore, the condition of the pus in the test tubes
resembles that in a cavity of a cold abcess, if the test tubes are kept at human
body temperature, 37°C. According to this idea, the test tubes of Series A and
B were plugged and sealed with wax and were kept in an incubator for one and
for twenty-four hours, so that the caseous mass acted upon the streptomycin
added to it for these periods. Series C was also kept in the incubator for the
same time and under the same conditions.
4) Thereafter, streptomycin concentration in each tube of Series A and B
was assayed by the vertical diffusion method7 ,16,24). In Series A, the cold pus
was centrifuged and then the assay was done on the pus serum and in Series B,
the assay was done on the pus serum. Series C was used as a standard strepto-
mycin series for the assay.
2. Results
If the streptomycin is destroyed or adsorbed by the dead tissue of caseous
mass, the concentration in Series A should be lower than Series B, because the
former Series contains caseous mass and the latter does not. If this is true,
streptomycin concentration in Series A should be lower after twenty-four hours
than after one hour, consequently the difference between the two series should
become increasingly larger.
From the results of the assay, it became evident unexpectedly that the con-
centration in Series A was higher than in Series B, and the difference between
the two series after twenty-four hours was less than that after one hour.
In the following figures, logarithmic scales were used to demonstrate the
results; the assayed streptomycin concentrations were shown on the vertical
axis and the number of tubes, namely the calculated concentrations were on the
horizontal axis.
Streptomycin concentrations in Series A and B after one hour are shown in
figures from 1 to 6. In all cases the concentrations in Series A were higher
than in Series B.
The concentrations assayed after twenty-four hours are shown in figures
from 7 to 15. In these cases, the differrence of the concentration between both
series became less remarkable than those after one hour. Thus, the anticipated
results of the experiment have been disproved. In the experiments shown in
figures 4 and 12, 5 and 14, and 6 and 15, each pair represents cold pus obtained
from a single patient at one time. Since a large quantity of cold pus was obtained
in these three cases, the concentration after one hour and after twenty-four hours
could be a£sayed and the comparison was made in the ~ame material. The results
are therefore believed to be more reliable.
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Fig. 1. Case 1., K.Z., 28 years-old man, with gravitation abscesses at the both
iliac grooves from tuberculosis of the lumbar spine. The material of





























0.1 0.4 1.6 6.3
(11) (9) (7) (5)
* The concentration calculated
** (Number of test tubes)
25 100/' / ml.'1'
(3) (1)**
at the addition.
No. of tubes I 11 I 10 I 9 I 8 I 7 I 6 I 5 I 4 I 3 \ 2 \ 1
I
The concentra- A 0.44 0.88 1.61 3.72 6.22 12.7 24.6 50.91 121.7 290.3 603.1
tion assayed
(y Iml) B 0.1 0.19 0.36 0.7 1.59 2.71 5.2 10.12 20.9 43.7 91.2
Fig. 2. Case 1., K.Z., 28 years-old man, with gravitation abscesses at the both
iliac grooves from tuberculosis of the lumber spine. The material of
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Fig. 3. Case 2., K.O., 52 years-old man, with a gravitation abcess at the
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* The concentration calculated at the addition.
** (Number of test tubes)
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..
--',- .
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I 5 I 4 J_3_L.2_ .. L.l_
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Fig. 4. Case 3., H.R., 30 years-old man, with a gravitation abcess at the
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Fi~. 5. Case 4., K.B., 32 years-old man, with a gravitation abcess at the
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(11) (9) (7) (5) (3) (1)**
* The concentration calculated at the addition.
** (Number of test tubes)
No. of tubes I 11 I 10 I 9 I 8 I 7 I 6 I 5 I 4 I 31 2 I 1
~~~ ~~~~~~::-a A0.36 0:76 1.57129 5:2--9.01 184 f37.3 I 78.2 1 165.3 III 379.0
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Fig. 6. Case 5., N.H., 37 years-old man, with a gravitation abcess at the
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Fig. 7. Case 6., F.]., 22 years-old man, with a gravitation abcess at the
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** (Number of test tubes)
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Fig. 8. Case 7., R.S., 27 years-old man, with a gravitation abcesg at the
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* The concentration calculated at the addition.
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Fig. 9. Case 8., K.M., 24 years-old man, with a gravitation abcess at the
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I
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Fig. 10. Case 9., K.Y., 50 years-old woman, with a gravitation abcess at
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Fig. 11. Case 10., G.M., 42 years-old woman, with a gravitation abcess


















* The concentration calculated at the addition.
** (Number of test tubes)
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Fig. 12. Case 3., H.R., 30 years-old man, with a gravitation abcess at
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Fig. 13. Case 11., H.H., 39 years-old woman, with a gravitation abcess









* The concentration calculated at the addition.
** (Number of test tubes)
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The concentra- A 0.1 0.19 0.39 0.75 1.4 2.9
tion assayed
(?,/ml) B 0.1 0.18 0.35 0.64 1.29 2.81
Fig. 14. Case 4., K.B., 32 years-old man, with a gravitation abcess at



























0.1 0,4 1.6 6.3 25 100 'Y" m!.'
(11) (9) (7) (5) (3) (1)**
* The concentration calculated at the addition.















Experimental Studies on the Distribution of Streptomycin
in the Tuberculous Foci of Bone and foint
Fig. 15. Case 5., N.H., 37 years-old man, with a gravitation abcess at
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The reason why the concentration of streptomycin in Series A is higher
than that of Series B after one hour might be explained that the penetration
velocity of streptomycin into caseous mass is very slow and the majority of the
drug might still have remained in the pus serum in the test tubes of Series A,
while the drug itself can neither be destroyed nor adsorbed by the tuberculous
dead tissue of caseous mass. In the pus serum of Series B, the streptomycin
had been dispersed throughout the larger volume of pus serum.
With lapse of time, the quantity of streptomycin penetrating into the caseous
mass might have increased. After twenty-four hours, the drug became evenly
distributed in each tube of Series A. Therefore the concentration in the separated
pus serum in Series A approached that of Series B, in which the distribution
had been homogenous from the beginning of the incubation.
In other words, from the results of this experiment, the hypothesis about
the difficulty of streptomycin penetration into caseous dead tissue was verified
in vitro. It was also proved that the difficulty of penetration was not caused by
a chemical reaction of the caseous mass.
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Moreover, in this experiment, the cold pus was homogenized in order to
provide each test tubes of Series A with material of uniform quality. Accor-
dingly, penetration of the drug into the caseous mass of the focus in human body
might be more difficult.
The results of this experiment support those of the clinical experiment15) in
which the bacteriostatic concentration of the drug was not found in the dead
tissues of the tuberculous foci. Thus, the difficulty of streptomycin penetration
into the dead tissues has been demonstrated in vivo and in vitro. Namely, it may
be said that besides bacteriostatic action, an essential requirement for a tuber-
culostatic is the ability for the drug to penetrate into the tissues of the focus.
Recently, various tuberculostatics other than streptomycin have been intro-
duced. The penetrating ability of these drugs can be tested and compared with
each other by the method mentioned above: the time which is needed for the
concentration of Series A to approach and correspond to Series B can be com-
pared if the assay is done with same cold pus for each drug.
The results of such experiments will be reported in the next paper.
IV. Conclusion
As published in the previous report15), the considerable concentration of
streptomycin was sometimes found in pus serum of the foci when the drug was
administered intramuscularly. Of course, the higher concentration of streptomycin
would be found in the pus serum if the drug is administered directly through
injection into the cold abscess. But it seems difficult for streptomycin to penetrate
into caseous mass or dead tissue of the foci, sufficiently to inhibit the bacilli,
even if considerable concentration were maintained in the pus serum, either by
intramuscular injection or by injection into the foci.
This opinion has been supported by the experiment zn vitro. Accordingly,
it seems difficult for the drug to act upon the bacilli surrounded by caseous
mass, sequestra, and other dead tissues of the foci.
These results in the experiment in vitro also suggest the limitation of the
conservative treatment for bone and joint tuberculosis, which has been discussed
in the clinical experiment15).
From the results in experiments both in vivo and in vitro, it has become
evident that debridement of the foci, removal of dead tissue, is necessary so
that the caseous foci of bone and joint can be completely healed in a shorter
period of time. These surgical procedures should be performed as completely
as possible so that no citadels of tubercle bacilli which can not be attacked with
streptomycin alone will remain.
14
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In former days, one of the most important problems and the most difficult
obstacles to overcome was that of finding a drug which could penetrate into the
wax capsule of tubercle bacilli. After the introduction of streptomycin, it has
become possible for the bacilli to be attacked directly. The most difficult
hindrance seems not to penetrate into the wax capsule, but to penetrate the
fibrous wall, necrotic substance, and caseous dead tissues surrounding the foci.
These results also suggest that the penetration ability of antibiotics is one
of the most important factors in chemotherapy, above all for tuberculosis. Under
certain circumstances, the ability of a drug to penetrate is more important than
chemotherapeutic index itself. However effective the bacteriortatic action of the
drug may be, it can not act upon the bacilli, unless enough concentration of the
antibiotic penetrates into foci to inhibit them. This condition seems more im-
portant in chronic tuberculosis than in other diseases because in chronic tuber-
culisis the foci contain caseous mass and dead tissues which are separated from
general circulation, whether the foci are extra-pulmonary or not. Nevertheless,
the principal object in studies on antibiotics so far, including tuberculostatics,
has been confined to the chemotherapeutic index alone. Penetration of the drug
into foci has been studied in an animal or a human body previously administered
with the drug.
On the contrary, by the application of the present mothod, measurement of
the penetration ability of several tuberculostatics into caseous foci has now
become possible in vitro, whether the drug is used at present or may be dis-
covered in the future. Accordingly, it is desirable that this study should be
examined, estimated, and utilized by many researchers who are studying tuber-
culosis and antibiotics.
V. Summary
To explain the low concentration of streptomycin in the foci of bone and
joint tuberculosis examined by the vertical diffusion method, above all in the
dead tissues, the author did an experiment in vitro. The experiment was carried
out with cold pus and pus serum each of which streptomycin was added to.
The effect of the caseous mass contained in the cold pus upon streptomycin was
examined using the pus serum as a control. The results of this experiment
show that the streptomycin is neither destroyed nor adsorbed by the caseous
mass, while the penetration ability of the drug into caseous mass is very poor.
Accordingly, the accuracy of the vertical diffusion method for the assay of
streptomycin concentration in the dead tissue of the tuberculous foci of bone
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